Summit Therapeutics, Inc. · 3 days ago
Regulatory Affairs Intern
Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on improving quality of life and resolving serious unmet medical needs. They are seeking a Regulatory Affairs Intern to gain hands-on experience in the RA life cycle process, working closely with the Regulatory Affairs Leadership team.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Work with assigned mentors on projects to help improve leadership, problem solving, and critical thinking skills
Assist with life-cycle regulatory activities
Support projects overseen by regulatory leads; will be required to manage their time appropriately with some supervision
Give a final presentation on assigned project
Participate in certain department activities and initiatives related to the project
Qualification
Required
Currently enrolled full-time in a graduate program (MD, PhD, PharmD), pursuing a degree majoring in a biological sciences, healthcare science (pharmacy or medical)
Pharm D Students that are currently enrolled in P2 and P3 along with those that are enrolled in master's degree from an accredited DRA Program are also encouraged to apply
Possess an understanding of regulatory science and clinical drug development through coursework or experience
Demonstrate ability to work on teams
Strong interpersonal, verbal communication and writing skills
Strong analytical and problem-solving skills, ability to be resourceful
Detail-oriented, highly motivated, able to manage multiple tasks and to work independently and as a team member
Possess proficient computer skills, including Microsoft Office Suite (Word, PowerPoint, and Excel)
Must be able to effectively multi-task and manage time-sensitive and highly confidential documents
Currently authorized to work in the United States without sponsorship
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
Funding
Current Stage
Public CompanyTotal Funding
$1.79BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2025-10-21Post Ipo Equity· $500M
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
Recent News
2025-12-09
2025-12-05
Company data provided by crunchbase